Claire Snowdon

A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer

R. Charles Coombes, Emma Hall, Lorna J. Gibson et al. · New England Journal of Medicine · 2004 · 1.8K citations · Full text

Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study

Robert E. Coleman, Linda M. Banks, Samia I. Girgis et al. · The Lancet Oncology · 2007 · 424 citations

Bone Disease, Bone Biomarkers, Breast Oncology +12

Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial

Nicholas C. Turner, Belinda Kingston, Lucy Kilburn et al. · The Lancet Oncology · 2020 · 334 citations · Full text

Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor–Positive Early Breast Cancer: PALLET Trial

Stephen Johnston, Shannon Puhalla, Duncan Wheatley et al. · Journal of Clinical Oncology · 2018 · 224 citations · Full text

Quality of Life in the Intergroup Exemestane Study: A Randomized Trial of Exemestane Versus Continued Tamoxifen After 2 to 3 Years of Tamoxifen in Postmenopausal Women With Primary Breast Cancer

Lesley Fallowfield, Judith M. Bliss, Lucy Porter et al. · Journal of Clinical Oncology · 2006 · 178 citations · Full text